Literature DB >> 3125042

Evidence from Sertoli cell-depleted rats indicates that spermatid number in adults depends on numbers of Sertoli cells produced during perinatal development.

J M Orth1, G L Gunsalus, A A Lamperti.   

Abstract

To probe the relationship between the size of the Sertoli cell population, established during perinatal development, and production of germ cells in the adult testis, a Sertoli cell-depleted rat model was developed. This was accomplished by delivering an antimitotic drug, cytosine arabinoside (araC), directly to the testis of newborn pups. Initial studies of these araC-treated neonates indicated that 1) the drug is cleared rapidly from the testis; 2) it substantially reduces the level of Sertoli cell proliferation; 3) Sertoli cell division ceases at a normal time in spite of the previous drug treatment; and 4) araC itself has no residual effect on germ cell proliferation, which begins several days after the injection. Pups given araC were allowed to reach maturity, and their testes were perfuse-fixed for light microscopic morphometry. When the numbers of Sertoli cells in adult rats given araC as were compared with those in normal littermates, a 54% decrease in the size of the Sertoli cell population was detected in treated rats, now referred to as Sertoli cell-depleted. Moreover, when round spermatids were quantified and compared in normal and Sertoli cell-depleted adults, testes of the latter were found to contain 55% fewer round spermatids. Since, in the araC-treated group, the decrease in Sertoli cell population size was paralleled by a reduction in spermatid production of equal magnitude, the number of round spermatids per Sertoli cell was essentially identical in normal and Sertoli cell-depleted animals. Measurements of serum androgen-binding protein (ABP) and FSH in both groups indicated that the circulating level of ABP in Sertoli cell-depleted rats was approximately half, and the concentration of FSH approximately twice, that in normal animals. Thus, even though FSH is elevated in Sertoli cell-depleted rats, the production of ABP per Sertoli cell is unchanged. In addition, collective volume of Leydig cells and ventral prostate weights were normal in the Sertoli cell-depleted group, suggesting that Leydig cell function in these rats is normal. In summary, a Sertoli cell-depleted rat model has been produced by interfering specifically with Sertoli cell proliferation early in postnatal life, before onset of germ cell division. Moreover, our findings with this model indicate that production of normal numbers of germ cells in adults depends, at least in part, on the size of the Sertoli cell population. Thus, our observations identify the perinatal period, when the Sertoli cell population is established, as critical for development of quantitatively normal spermatogenesis in the adult.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3125042     DOI: 10.1210/endo-122-3-787

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  104 in total

1.  Endocrine disrupting chemicals: Multiple effects on testicular signaling and spermatogenesis.

Authors:  Bonnie Hy Yeung; Hin T Wan; Alice Ys Law; Chris Kc Wong
Journal:  Spermatogenesis       Date:  2011-07-01

2.  Testicular connexin 43, a precocious molecular target for the effect of environmental toxicants on male fertility.

Authors:  Georges Pointis; Jérôme Gilleron; Diane Carette; Dominique Segretain
Journal:  Spermatogenesis       Date:  2011-10-01

3.  Activin A, a product of fetal Leydig cells, is a unique paracrine regulator of Sertoli cell proliferation and fetal testis cord expansion.

Authors:  Denise R Archambeault; Humphrey Hung-Chang Yao
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-24       Impact factor: 11.205

4.  Overexpression of follistatin in the mouse epididymis disrupts fluid resorption and sperm transit in testicular excurrent ducts.

Authors:  Darcie D Seachrist; Emhonta Johnson; Christianne Magee; Colin M Clay; James K Graham; D N Rao Veeramachaneni; Ruth A Keri
Journal:  Biol Reprod       Date:  2012-08-23       Impact factor: 4.285

Review 5.  Androgen receptor roles in spermatogenesis and fertility: lessons from testicular cell-specific androgen receptor knockout mice.

Authors:  Ruey-Sheng Wang; Shuyuan Yeh; Chii-Ruey Tzeng; Chawnshang Chang
Journal:  Endocr Rev       Date:  2009-01-27       Impact factor: 19.871

6.  Sertoli cell Dicer is essential for spermatogenesis in mice.

Authors:  Marilena D Papaioannou; Jean-Luc Pitetti; Seungil Ro; Chanjae Park; Florence Aubry; Olivier Schaad; Charles E Vejnar; Francoise Kühne; Patrick Descombes; Evgeny M Zdobnov; Michael T McManus; Florian Guillou; Brian D Harfe; Wei Yan; Bernard Jégou; Serge Nef
Journal:  Dev Biol       Date:  2008-11-28       Impact factor: 3.582

7.  Effect of allopurinol on germ cell apoptosis following testicular ischemia-reperfusion injury in a rat.

Authors:  Igor Sukhotnik; Gil Meyer; Ofer Nativ; Arnold G Coran; Katya Voskoboinik; Eitan Shiloni; Jorge G Mogilner
Journal:  Pediatr Surg Int       Date:  2008-01       Impact factor: 1.827

8.  Long-term vitamin A deficiency induces alteration of adult mouse spermatogenesis and spermatogonial differentiation: direct effect on spermatogonial gene expression and indirect effects via somatic cells.

Authors:  Catherine Boucheron-Houston; Lucile Canterel-Thouennon; Tin-Lap Lee; Vanessa Baxendale; Sohan Nagrani; Wai-Yee Chan; Owen M Rennert
Journal:  J Nutr Biochem       Date:  2012-12-17       Impact factor: 6.048

9.  Methotrexate induces germ cell apoptosis and impairs spermatogenesis in a rat.

Authors:  Igor Sukhotnik; Omri Nativ; Alex Roitburt; Daniel Bejar; Arnold G Coran; Jorge G Mogilner; Ofer Nativ
Journal:  Pediatr Surg Int       Date:  2013-02       Impact factor: 1.827

10.  Immature rat seminiferous tubules reconstructed in vitro express markers of Sertoli cell maturation after xenografting into nude mouse hosts.

Authors:  K Gassei; J Ehmcke; M A Wood; W H Walker; S Schlatt
Journal:  Mol Hum Reprod       Date:  2009-09-21       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.